Por favor, use este identificador para citar o enlazar este ítem:http://uvadoc.uva.es/handle/10324/43078
Título
The problem of benzodiazepine use and Its extent in the driver population: A population-based registry study
Autor
Año del Documento
2018
Editorial
Frontiers
Descripción
Producción Científica
Documento Fuente
Frontiers in Pharmacology, 2018, vol. 9. 9 p.
Resumen
Background: Benzodiazepines are driving-impairing medicines (DIM). This study presents current consumption of dispensed benzodiazepines in the Spanish general population, with a focus in pattern of use and concomitant medicines consumed with.
Methods: A population-based registry study was carried out to assess the year-2016 granted benzodiazepines dispensation in Castile and León. Weighting was performed to obtain the adjusted benzodiazepine consumption for licensed drivers according to age and gender using our national drivers' license census data.
Results: Benzodiazepines were used by 15.38% of the general population and 10.97% of drivers. Nearly 2% of the population and more than 1% of drivers took these medicines every day. The amount consumed (until 3 or more benzodiazepines per day) and concomitant use of other DIM were also higher. Women were the most frequent consumers, and anxiolytic use was usual. Consumption increases with age, but there were differences between men and women drivers from 60 years old.
Conclusions: The current use of benzodiazepines must serve to awareness of the healthcare personnel, patients, and authorities on their risks, above all on the road safety.
Palabras Clave
Traffic accidents
Accidentes de tráfico
Driving
Conducción
Benzodiazepines
Benzodiazepinas
ISSN
1663-9812
Revisión por pares
SI
Patrocinador
Instituto de Salud Carlos III (grant RD16/0017/0006)
Version del Editor
Propietario de los Derechos
© 2018 Frontiers
Idioma
eng
Tipo de versión
info:eu-repo/semantics/publishedVersion
Derechos
openAccess
Aparece en las colecciones
Ficheros en el ítem
La licencia del ítem se describe como Attribution-NonCommercial-NoDerivatives 4.0 Internacional